• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用新冠病毒中的天然有毒代谢产物

Harnessing the Natural Toxic Metabolites in COVID-19.

作者信息

Bahrami Ali, Taheri Mohammad, Arabestani Mohammad Reza, Soleimani Meysam, Mohammadi Mojdeh, Golabchi Fatemeh, Banitorfi Maryam, Hosseini Seyed Mostafa, Khodabandehlou Sodabe, Nouri Fatemeh

机构信息

Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.

Department of Pharmaceutical Biotechnology, School of Pharmacy, Hamadan University of Medical Scienceaffs, Hamadan, Iran.

出版信息

Evid Based Complement Alternat Med. 2022 Mar 7;2022:3954944. doi: 10.1155/2022/3954944. eCollection 2022.

DOI:10.1155/2022/3954944
PMID:35273645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8902635/
Abstract

SARS-CoV-2 is a novel coronavirus and the cause of the recent pandemic; it is an enveloped -coronavirus. SARS-CoV-2 appear in the Wuhan City of China for the first time and outspread worldwide quickly. Due to its person-to-person fast transmission, COVID-19 is becoming a global problem. SARS-CoV-2 enter into cells by using ACE2 receptors that are numerous in the lungs and finally can cause acute respiratory distress syndrome (ARDS). Dry cough, sore throat, fever, body pain, headache, GIT discomfort, diarrhoea, and fatigue are some of the COVID-19 symptoms. There is no definite and certain treatment for disease caused by SARS-CoV-2 till now. Some pharmacological effects of toxins, toxoids, and venoms have been proven, and their effects on some diseases have been evaluated. This study aimed to investigate the role of toxins, toxoids, and venom in the pathophysiology of COVID-19 disease.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是一种新型冠状病毒,也是近期大流行的病原体;它是一种包膜冠状病毒。SARS-CoV-2首次出现在中国武汉市,并迅速在全球传播。由于其人际传播速度快,新型冠状病毒肺炎(COVID-19)正成为一个全球性问题。SARS-CoV-2通过利用肺部大量存在的血管紧张素转换酶2(ACE2)受体进入细胞,最终可导致急性呼吸窘迫综合征(ARDS)。干咳、咽痛、发热、身体疼痛、头痛、胃肠道不适、腹泻和疲劳是COVID-19的一些症状。迄今为止,对于由SARS-CoV-2引起的疾病尚无确切的治疗方法。毒素、类毒素和毒液的一些药理作用已得到证实,并且已经评估了它们对某些疾病的影响。本研究旨在探讨毒素、类毒素和毒液在COVID-19疾病病理生理学中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d4c/8902635/28c60d7232d3/ECAM2022-3954944.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d4c/8902635/28c60d7232d3/ECAM2022-3954944.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d4c/8902635/28c60d7232d3/ECAM2022-3954944.001.jpg

相似文献

1
Harnessing the Natural Toxic Metabolites in COVID-19.利用新冠病毒中的天然有毒代谢产物
Evid Based Complement Alternat Med. 2022 Mar 7;2022:3954944. doi: 10.1155/2022/3954944. eCollection 2022.
2
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病(COVID-19)疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
3
Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective.从分子机制和免疫反应角度治疗新冠肺炎的当前方法。
Saudi Pharm J. 2020 Nov;28(11):1333-1352. doi: 10.1016/j.jsps.2020.08.024. Epub 2020 Sep 1.
4
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.COVID-19 患者的激肽释放酶-激肽系统阻断治疗以预防急性呼吸窘迫综合征。
Elife. 2020 Apr 27;9:e57555. doi: 10.7554/eLife.57555.
5
Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.在新冠疫情早期,一家筛查诊所的冠状病毒病(COVID-19)病例的流行病学和临床特征:一项单中心研究。
J Med Microbiol. 2020 Aug;69(8):1114-1123. doi: 10.1099/jmm.0.001231.
6
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.新型严重急性呼吸系统综合症冠状病毒 2(SARS-CoV-2)的爆发:当前全球状况综述。
J Infect Public Health. 2020 Nov;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011. Epub 2020 Aug 4.
7
Coronavirus disease 2019 (COVID-19) and pediatric gastroenterology.2019冠状病毒病(COVID-19)与儿童胃肠病学
Gastroenterol Hepatol Bed Bench. 2020 Fall;13(4):351-354.
8
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Nervous System: Implications of COVID-19 in Neurodegeneration.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对神经系统的影响:2019冠状病毒病(COVID-19)在神经退行性变中的意义。
Front Neurol. 2020 Nov 16;11:583459. doi: 10.3389/fneur.2020.583459. eCollection 2020.
9
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
10
Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.中国武汉 116 例 COVID-19 住院患者的临床特征:一项以医院为中心、回顾性、观察性研究。
BMC Infect Dis. 2020 Oct 22;20(1):787. doi: 10.1186/s12879-020-05452-2.

引用本文的文献

1
Pharmacological modes of plant-derived compounds for targeting inflammation in rheumatoid arthritis: A comprehensive review on immunomodulatory perspective.植物源化合物靶向类风湿关节炎炎症的药理模式:基于免疫调节视角的综述
Inflammopharmacology. 2025 Apr;33(4):1537-1581. doi: 10.1007/s10787-025-01664-7. Epub 2025 Mar 13.

本文引用的文献

1
Snake venom phospholipase As exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2.蛇毒磷脂酶 A2 对 SARS-CoV-2 表现出强烈的抗病毒活性,并抑制病毒刺突糖蛋白与 ACE2 的相互作用。
Cell Mol Life Sci. 2021 Dec;78(23):7777-7794. doi: 10.1007/s00018-021-03985-6. Epub 2021 Oct 29.
2
State-of-the-art review - A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis?前沿综述 - 蛇毒来源的抗血栓药物综述:COVID-19 相关血栓形成的潜在治疗方法?
Int J Biol Macromol. 2021 Dec 1;192:1040-1057. doi: 10.1016/j.ijbiomac.2021.10.015. Epub 2021 Oct 14.
3
Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.
蛇毒来源的生物活性分子具有治疗 COVID-19 相关血栓心血管疾病的潜力。
Protein J. 2021 Dec;40(6):799-841. doi: 10.1007/s10930-021-10019-4. Epub 2021 Sep 9.
4
Exploring the Role of Heavy Metals and Their Derivatives on the Pathophysiology of COVID-19.探讨重金属及其衍生物在 COVID-19 病理生理学中的作用。
Biol Trace Elem Res. 2022 Jun;200(6):2639-2650. doi: 10.1007/s12011-021-02893-x. Epub 2021 Aug 27.
5
Could treatment with botulinum toxin protect against subsequent infection with COVID-19?肉毒杆菌毒素治疗能否预防 COVID-19 的后续感染?
J Stomatol Oral Maxillofac Surg. 2022 Apr;123(2):98-100. doi: 10.1016/j.jormas.2021.06.003. Epub 2021 Jun 16.
6
Interactions of SARS-CoV-2 with the Blood-Brain Barrier.SARS-CoV-2 与血脑屏障的相互作用。
Int J Mol Sci. 2021 Mar 6;22(5):2681. doi: 10.3390/ijms22052681.
7
Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations.对免疫记录的探索性分析表明,近期接种过非 COVID-19 疫苗的个体中 SARS-CoV-2 感染率降低。
Sci Rep. 2021 Feb 26;11(1):4741. doi: 10.1038/s41598-021-83641-y.
8
Fighting against the second wave of COVID-19: Can honeybee products help protect against the pandemic?抗击新冠疫情第二波:蜂产品能帮助预防大流行吗?
Saudi J Biol Sci. 2021 Mar;28(3):1519-1527. doi: 10.1016/j.sjbs.2020.12.031. Epub 2020 Dec 22.
9
A review of potential suggested drugs for coronavirus disease (COVID-19) treatment.治疗冠状病毒病 (COVID-19) 的潜在建议药物综述。
Eur J Pharmacol. 2021 Mar 15;895:173890. doi: 10.1016/j.ejphar.2021.173890. Epub 2021 Jan 20.
10
Bee Venom-A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections.蜂毒——一种用于 SARS-CoV-2 感染的潜在补充医学候选药物。
Front Public Health. 2020 Dec 10;8:594458. doi: 10.3389/fpubh.2020.594458. eCollection 2020.